Chemotherapy-induced peripheral neuropathy
Conditions
Interventions
Control Group:Watch the video
Treatment Group:acupuncture
Sponsors
Jiangsu Provincial Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Patients with histological diagnosis of stage I-III breast cancer, excluding distant metastases (2) Patients who plan to receive adjuvant or neoadjuvant chemotherapy (with or without HER-2 targeted therapy) must be enrolled before the second adjuvant chemotherapy. (3) Over 18 years of age (4) Sign informed consent 6. No serious organic damage to heart, kidney, liver or brain; 7. Signed the informed consent, participated in and randomly assigned to a study group with no history of substance abuse, and actively cooperated with treatment and follow-up.
Exclusion criteria
Exclusion criteria: (1) Previous CIPN-causing chemotherapy (one dose of chemotherapy allowed). (2) There were unstable heart disease and myocardial infarction in the first six months (3) Have a pacemaker or implantable cardioverter defibrillator (4) Uncontrollable seizures (5) Prior peripheral neuropathy (PRO-CTCAE CIPN Scale) (6) Acupuncture within three months before enrollment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| EORTC QLQ-CIPN20 scale mean change value; | — |
Secondary
| Measure | Time frame |
|---|---|
| QLQ-C30 Scale;KPS;NRS Scale; | — |
Countries
China
Contacts
Public ContactYao Chang
Outcome results
None listed